News | April 11, 2026
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
20 among them to receive $20,000 grants
At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans
Subscribe To Our Newsletter & Stay Updated
